Black-swan watch: emergent clusters, actions losing effect, co-occurrence patterns across layers, adverse signals in responders, tracker anomalies across the program. A human sets the state.

What is emerging that nobody predicted?

Synthetic demo data

watchclusterEC-03 · High response / high intolerance

Early response followed by GI deterioration and treatment discontinuation.

first seen day 36n 9056 days before clinical recognition

P-02008 P-02014 P-02022 P-02028 P-02048 P-02076 P-02107 P-02132 P-02142 P-02144 P-02150 P-02153 P-02156 P-02170 P-02172 P-02178+74

watchtracker anomalySleep quality falling across the program where GI is rising

57 patients (8%) with worsening sleep and GI ≥ 40 in the same 14 days; sleep-window content is the cheapest lever.

first seen last 14 daysn 57

P-02008 P-02009 P-02014 P-02022 P-02028 P-02035 P-02048 P-02053 P-02113 P-02132 P-02139 P-02153 P-02162 P-02172 P-02188 P-02202+41

watchclusterEC-01 · Delayed loss of response

Response builds, then fades from the second month without a toxicity signal.

first seen day 68n 4962 days before clinical recognition

P-02003 P-02034 P-02056 P-02070 P-02084 P-02088 P-02124 P-02183 P-02186 P-02197 P-02198 P-02201 P-02214 P-02225 P-02231 P-02248+33

watchclusterEC-02 · Resilient responder

Strong response that survives an early toxicity episode.

first seen day 25n 2547 days before clinical recognition

P-02013 P-02058 P-02073 P-02081 P-02095 P-02096 P-02195 P-02200 P-02297 P-02312 P-02320 P-02321 P-02338 P-02342 P-02346 P-02389+9

watchco occurrenceGI burden + low mood + falling HRV in the same patients

A gut–mood–autonomic pattern that no single side-effect view shows. 20% carry the IL6 variant, 40% low butyrate.

first seen this windown 50% vs 30 d ago

P-02272 P-02369 P-02491 P-02543 P-02700